ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 516

Microalbuminuria in Rheumatoid Arthritis: Investigating the Association with Diffuse Functional and Morphological Alterations of the Retinal Microvasculature, the Dermal Capillary Network and the Coronary Microcirculation

Panagiota Anyfanti1, Areti Triantafyllou1, Eugenia Gkaliagkousi1, Xenophon Zabulis2, Sophia Chatzimichailidou3, Vasiliki Galanopoulou4, Stella Douma1 and Spyros Aslanidis3, 13rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece, Thessaloniki, Greece, 2Institute of Computer Science, Foundation for Research and Technology-Hellas (FORTH), Heraklion, Greece, Heraklion, Greece, 3Rheumatology Department-2nd Propedeutic Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece, Thessaloniki, Greece, 4Rheumatology Department, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece, Thessaloniki, Greece

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I: Comorbidities

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Increased urinary albumin excretion (UAE) is an early marker of renal microvascular damage that correlates with cardiovascular risk and corresponds to a state of generalized microvascular impairment, even below the threshold values usually considered for microalbuminuria (30-300 mg in a 24h urine sample). However, data regarding prevalence of microalbuminuria are conflicting in patients with rheumatoid arthritis (RA), a disease characterized by excess cardiovascular risk. Moreover, it remains unclear whether it corresponds to a state of generalized microvascular dysfunction in this particular group of patients. We investigated for the first time whether microalbuminuria is associated with other forms of microvascular impairment located in the dermal capillary network, the retinal and the coronary microvasculature.

Methods:

24h urine samples were obtained from RA and non-RA individuals to estimate UAE. Morphological changes in the retinal microvasculature were evaluated from retinal photography. Retinal images were processed with specifically designed computerized software that calculates retinal arteriolar and venular diameters, to obtain central retinal arteriolar equivalent (CRAE) and central retinal venular equivalent (CRVE), as well as their ratio (arteriovenous ratio, AVR). Functional assessment of the coronary artery network was based on measurement of the subendocardial viability index (SEVR), a non-invasive estimate of microvascular coronary perfusion, using radial artery applanation tonometry. Dermal capillary rarefaction was evaluated with nailfold capillaroscopy applied in the distant phalanx of the fingers, using semi automated software that calculates capillary density in the obtained images.

Results:

A total of 111 individuals were studied, of whom 74 were RA patients with long-standing disease [9 (4–16.5) years], moderate disease activity (DAS score: 3.6±1.4), and relatively low levels of systemic inflammation, and 37 were matched controls. Patients with RA presented narrower retinal arterioles, shown by decreased CRAE (78.0±8.9 vs 87.4±10.0 μm, p<0.001) and AVR (0.69±0.10 vs 0.78±0.10, p<0.001); impaired coronary microvascular perfusion, shown by decreased SEVR (140.6±22.3 vs 150.7±21.6 %, p=0.038), and pronounced capillary rarefaction, reflected in a lower number of dermal capillaries per visual field (132.5±28.2 vs 151.2±25.6, p=0.007), compared to controls. By contrast, neither UAE [5.1 (2.8 – 10.8) vs 6.5 (3.0 – 11.7) mg/24h] nor prevalence of microalbuminuria (11.0 vs 8.1%) differed between patients and controls (p=ns for both). In the RA group, UAE was not significantly associated with inflammation or other disease-related parameters, nor with any of the studied microvascular indices of the coronary microcirculation, the retinal microvasculature, and the dermal capillary network.

Conclusion:

In our population of RA individuals, microalbuminuria was not associated with morphological and functional alterations in distal microvascular beds. Increased UAE in RA patients might be primarily considered as a manifestation of compromised function of the renal microvasculature, rather than a marker of generalized microvascular dysfunction.


Disclosure: P. Anyfanti, None; A. Triantafyllou, None; E. Gkaliagkousi, None; X. Zabulis, None; S. Chatzimichailidou, None; V. Galanopoulou, None; S. Douma, None; S. Aslanidis, None.

To cite this abstract in AMA style:

Anyfanti P, Triantafyllou A, Gkaliagkousi E, Zabulis X, Chatzimichailidou S, Galanopoulou V, Douma S, Aslanidis S. Microalbuminuria in Rheumatoid Arthritis: Investigating the Association with Diffuse Functional and Morphological Alterations of the Retinal Microvasculature, the Dermal Capillary Network and the Coronary Microcirculation [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/microalbuminuria-in-rheumatoid-arthritis-investigating-the-association-with-diffuse-functional-and-morphological-alterations-of-the-retinal-microvasculature-the-dermal-capillary-network-and-the-coro/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/microalbuminuria-in-rheumatoid-arthritis-investigating-the-association-with-diffuse-functional-and-morphological-alterations-of-the-retinal-microvasculature-the-dermal-capillary-network-and-the-coro/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology